Radius Health Completes Enrollment for Phase 3 Study of Bone-Building Osteoporosis Drug

CAMBRIDGE, MA -- (Marketwire) -- 03/12/13 -- ("Radius"), a biopharmaceutical company focused on developing new therapeutics…

Continue Reading

Radius Health to Present at BIO CEO & Investor in New York

CAMBRIDGE, MA -- (Marketwire) -- 02/08/13 -- ("Radius"), a biopharmaceutical company focused on developing new therapeutics…

Continue Reading